EP.07C.04 Adjuvant Aumolertinib in Resected Stage I EGFR-Mutated NSCLC: Prospectively Evaluating Efficacy in Residual GGN Lesions

Autor: Huang, C.B.
Zdroj: Journal of Thoracic Oncology; October 2024, Vol. 19 Issue: 10, Number 10 Supplement 1 pS540-S541, 2p
Databáze: Supplemental Index